Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 177

1.

Thyroid metastasis from esophageal adenocarcinoma: a case report and literature review.

Yumoto S, Baba Y, Nomoto D, Oozono K, Eto K, Hiyoshi Y, Nagai Y, Iwatsuki M, Iwagami S, Miyamoto Y, Yoshida N, Mikami Y, Baba H.

Surg Case Rep. 2019 Aug 30;5(1):137. doi: 10.1186/s40792-019-0695-5.

2.

Prognostic impacts of the combined positive score and the tumor proportion score for programmed death ligand-1 expression by double immunohistochemical staining in patients with advanced gastric cancer.

Yamashita K, Iwatsuki M, Harada K, Eto K, Hiyoshi Y, Ishimoto T, Nagai Y, Iwagami S, Miyamoto Y, Yoshida N, Komohara Y, Ajani JA, Baba H.

Gastric Cancer. 2019 Aug 26. doi: 10.1007/s10120-019-00999-9. [Epub ahead of print]

PMID:
31451991
3.

Risk factors and prognostic significance of lateral pelvic lymph node metastasis in advanced rectal cancer.

Hiyoshi Y, Miyamoto Y, Kiyozumi Y, Eto K, Nagai Y, Iwatsuki M, Iwagami S, Baba Y, Yoshida N, Baba H.

Int J Clin Oncol. 2019 Aug 12. doi: 10.1007/s10147-019-01523-w. [Epub ahead of print]

PMID:
31407167
4.

Is Oral Mucositis Occurring During Chemotherapy for Esophageal Cancer Patients Correctly Judged? EPOC Observational Cohort Study.

Tanaka Y, Ueno T, Yoshida N, Akutsu Y, Takeuchi H, Baba H, Matsubara H, Kitagawa Y, Yoshida K.

Anticancer Res. 2019 Aug;39(8):4441-4448. doi: 10.21873/anticanres.13616.

PMID:
31366542
5.

Intratumoral Fusobacterium Nucleatum Levels Predict Therapeutic Response to Neoadjuvant Chemotherapy in Esophageal Squamous Cell Carcinoma.

Yamamura K, Izumi D, Kandimalla R, Sonohara F, Baba Y, Yoshida N, Kodera Y, Baba H, Goel A.

Clin Cancer Res. 2019 Jul 29. doi: 10.1158/1078-0432.CCR-19-0318. [Epub ahead of print]

PMID:
31358543
6.

Can PD-L1 expression evaluated by biopsy sample accurately reflect its expression in the whole tumour in gastric cancer?

Yamashita K, Iwatsuki M, Harada K, Koga Y, Kiyozumi Y, Eto K, Hiyoshi Y, Ishimoto T, Iwagami S, Baba Y, Miyamoto Y, Yoshida N, Komohara Y, Ajani JA, Baba H.

Br J Cancer. 2019 Jul;121(3):278-280. doi: 10.1038/s41416-019-0515-5. Epub 2019 Jul 9.

PMID:
31285589
7.

The effect of a chin-down maneuver after esophagectomy on oropharyngeal swallowing pressure measured using high-resolution manometry.

Matsubara K, Kumai Y, Miyamoto T, Samejima Y, Yoshida N, Baba H, Orita Y.

Auris Nasus Larynx. 2019 Jun 13. pii: S0385-8146(19)30317-7. doi: 10.1016/j.anl.2019.06.001. [Epub ahead of print]

PMID:
31204048
8.

Clinical Importance of Sputum in the Respiratory Tract as a Predictive Marker of Postoperative Morbidity After Esophagectomy for Esophageal Cancer.

Yoshida N, Morito A, Nagai Y, Baba Y, Miyamoto Y, Iwagami S, Iwatsuki M, Hiyoshi Y, Eto K, Ishimoto T, Kiyozumi Y, Yagi T, Nomoto D, Akiyama T, Toihata T, Imamura Y, Watanabe M, Baba H.

Ann Surg Oncol. 2019 Aug;26(8):2580-2586. doi: 10.1245/s10434-019-07477-7. Epub 2019 May 29.

PMID:
31144141
9.

Clinical significance of evaluating endoscopic response to neoadjuvant chemotherapy in esophageal squamous cell carcinoma.

Nagai Y, Yoshida N, Baba Y, Harada K, Imai K, Iwatsuki M, Karashima R, Koga Y, Nomoto D, Okadome K, Ishimoto T, Imamura Y, Watanabe M, Baba H.

Dig Endosc. 2019 May 23. doi: 10.1111/den.13449. [Epub ahead of print]

PMID:
31120560
10.

IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal Cancer.

Kiyozumi Y, Baba Y, Okadome K, Yagi T, Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N, Watanabe M, Komohara Y, Baba H.

Ann Surg. 2019 Jun;269(6):1101-1108. doi: 10.1097/SLA.0000000000002754.

PMID:
31082908
11.

Indoleamine 2, 3-dioxygenase 1 promoter hypomethylation is associated with poor prognosis in patients with esophageal cancer.

Kiyozumi Y, Baba Y, Okadome K, Yagi T, Ogata Y, Eto K, Hiyoshi Y, Ishimoto T, Iwatsuki M, Iwagami S, Miyamoto Y, Yoshida N, Watanabe M, Baba H.

Cancer Sci. 2019 Jun;110(6):1863-1871. doi: 10.1111/cas.14028. Epub 2019 May 20.

12.

Risk factors for chylothorax after esophagectomy.

Yoshida N, Baba H.

J Thorac Dis. 2019 Mar;11(Suppl 3):S196-S197. doi: 10.21037/jtd.2019.02.28. No abstract available.

13.

Tumor Long-interspersed Nucleotide Element-1 Methylation Level and Immune Response to Esophageal Cancer.

Kosumi K, Baba Y, Okadome K, Yagi T, Kiyozumi Y, Yoshida N, Watanabe M, Baba H.

Ann Surg. 2019 Mar 26. doi: 10.1097/SLA.0000000000003264. [Epub ahead of print]

PMID:
30946079
14.

Preservation of physiological passage through the remnant stomach prevents postoperative malnutrition after proximal gastrectomy with double tract reconstruction.

Yamashita K, Iwatsuki M, Koga Y, Toihata T, Kiyozumi Y, Kuroda D, Eto K, Hiyoshi Y, Iwagami S, Baba Y, Miyamoto Y, Yoshida N, Baba H.

Surg Today. 2019 Sep;49(9):748-754. doi: 10.1007/s00595-019-01799-5. Epub 2019 Mar 30.

PMID:
30929080
15.

Disseminated carcinomatosis of the bone marrow from gastric cancer during pregnancy.

Kinoshita S, Yamashita K, Iwatsuki M, Sato H, Matsumoto C, Matsumoto T, Shiraishi Y, Yoshida N, Baba H.

Clin J Gastroenterol. 2019 Mar 26. doi: 10.1007/s12328-019-00963-1. [Epub ahead of print]

PMID:
30915672
16.

Effect of Resection of the Thoracic Duct and Surrounding Lymph Nodes on Short- and Long-Term and Nutritional Outcomes After Esophagectomy for Esophageal Cancer.

Yoshida N, Nagai Y, Baba Y, Miyamoto Y, Iwagami S, Iwatsuki M, Hiyoshi Y, Eto K, Ishimoto T, Kiyozumi Y, Nomoto D, Akiyama T, Imamura Y, Watanabe M, Baba H.

Ann Surg Oncol. 2019 Jun;26(6):1893-1900. doi: 10.1245/s10434-019-07304-z. Epub 2019 Mar 12.

PMID:
30863941
17.

Glucose transporter 1 regulates the proliferation and cisplatin sensitivity of esophageal cancer.

Sawayama H, Ogata Y, Ishimoto T, Mima K, Hiyoshi Y, Iwatsuki M, Baba Y, Miyamoto Y, Yoshida N, Baba H.

Cancer Sci. 2019 May;110(5):1705-1714. doi: 10.1111/cas.13995. Epub 2019 Apr 5.

18.

The role of FBXW7, a cell-cycle regulator, as a predictive marker of recurrence of gastrointestinal stromal tumors.

Koga Y, Iwatsuki M, Yamashita K, Kiyozumi Y, Kurashige J, Masuda T, Eto K, Iwagami S, Harada K, Ishimoto T, Baba Y, Yoshida N, Miyanari N, Takamori H, Ajani JA, Baba H.

Gastric Cancer. 2019 Mar 11. doi: 10.1007/s10120-019-00950-y. [Epub ahead of print]

PMID:
30854619
19.

Tumour-associated macrophages are associated with poor prognosis and programmed death ligand 1 expression in oesophageal cancer.

Yagi T, Baba Y, Okadome K, Kiyozumi Y, Hiyoshi Y, Ishimoto T, Iwatsuki M, Miyamoto Y, Yoshida N, Watanabe M, Komohara Y, Baba H.

Eur J Cancer. 2019 Apr;111:38-49. doi: 10.1016/j.ejca.2019.01.018. Epub 2019 Feb 26.

PMID:
30822683
20.

Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment.

Bu L, Baba H, Yoshida N, Miyake K, Yasuda T, Uchihara T, Tan P, Ishimoto T.

Oncogene. 2019 Jun;38(25):4887-4901. doi: 10.1038/s41388-019-0765-y. Epub 2019 Feb 28. Review.

PMID:
30816343

Supplemental Content

Loading ...
Support Center